- Home
- Publications
- Publication Search
- Publication Details
Title
Human anti-nucleolin recombinant immunoagent for cancer therapy
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 30, Pages 9418-9423
Publisher
Proceedings of the National Academy of Sciences
Online
2015-07-14
DOI
10.1073/pnas.1507087112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
- (2014) Marina Koutsioumpa et al. Recent Patents on Anti-Cancer Drug Discovery
- Downregulation of miR-21 Enhances Chemotherapeutic Effect of Taxol in Breast Carcinoma Cells
- (2014) Mei Mei et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex
- (2013) J. F. Wise et al. BLOOD
- A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
- (2013) Jonathan E. Rosenberg et al. INVESTIGATIONAL NEW DRUGS
- In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
- (2013) Flavia Pichiorri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- G0S2 inhibits the proliferation of K562 cells by interacting with nucleolin in the cytosol
- (2013) Takeshi Yamada et al. LEUKEMIA RESEARCH
- Aptamer imaging with Cu-64 labeled AS1411: Preliminary assessment in lung cancer
- (2013) Junling Li et al. NUCLEAR MEDICINE AND BIOLOGY
- Disrupting the Oncogenic Synergism between Nucleolin and Ras Results in Cell Growth Inhibition and Cell Death
- (2013) Sari Schokoroy et al. PLoS One
- Cell surface nucleolin is crucial in the activation of the CXCL12/CXCR4 signaling pathway
- (2013) Xiangshan Yang et al. TUMOR BIOLOGY
- Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L
- (2012) Charalampos Birmpas et al. BMC CELL BIOLOGY
- Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest
- (2012) Zhiqiang Xu et al. JOURNAL OF NEURO-ONCOLOGY
- Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells
- (2012) Nataša Anastasov et al. Radiation Oncology
- RNA-binding protein nucleolin in disease
- (2012) Kotb Abdelmohsen et al. RNA Biology
- Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type
- (2011) Bernard Krust et al. BMC CANCER
- Nucleolin Protein Interacts with Microprocessor Complex to Affect Biogenesis of MicroRNAs 15a and 16
- (2011) Brian F. Pickering et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of nucleolin as a cellular receptor for human respiratory syncytial virus
- (2011) Farnoosh Tayyari et al. NATURE MEDICINE
- Enhanced translation by Nucleolin via G-rich elements in coding and non-coding regions of target mRNAs
- (2011) Kotb Abdelmohsen et al. NUCLEIC ACIDS RESEARCH
- MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
- (2011) Maitri Y Shah et al. Genome Medicine
- Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice
- (2010) Diala El Khoury et al. BMC CANCER
- Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
- (2010) Igor P. Pogribny et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanism of Regulation ofbcl-2mRNA by Nucleolin and A+U-rich Element-binding Factor 1 (AUF1)
- (2010) Daniella Ishimaru et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA Cluster 221-222 and Estrogen Receptor α Interactions in Breast Cancer
- (2010) Gianpiero Di Leva et al. JNCI-Journal of the National Cancer Institute
- MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
- (2010) X Rao et al. ONCOGENE
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
- (2009) S. Soundararajan et al. MOLECULAR PHARMACOLOGY
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells
- (2008) S. Soundararajan et al. CANCER RESEARCH
- From ImmunoToxins to ImmunoRNases
- (2008) Claudia Lorenzo et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells
- (2008) E. Merit Reyes-Reyes et al. EXPERIMENTAL CELL RESEARCH
- Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma
- (2008) Lee Ridley et al. NEURO-ONCOLOGY
- Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin
- (2008) Damien Destouches et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search